LKB1 mutations are commonly found in several types of cancers, with a high prevalence in NSCLC. Besides lung cancer, LKB1 mutations are also observed in cancers such as pancreatic cancer, melanoma, colorectal cancer, and cervical cancer. The loss of LKB1 function in these cancers often correlates with poor prognosis and increased metastatic potential.
